About Algentech
Algentech is a company based in Evry-courcouronnes (France) founded in 2009.. Algentech has raised $253.19 thousand across 1 funding round from investors including Intuitis. Algentech offers products and services including Bioproduction Platform, Melanin, Antimicrobials, and Nucleic Acids. Algentech operates in a competitive market with competitors including GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter Evry-courcouronnes, France
-
Sectors
HealthcareAgriculture
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$253.19 K (USD)
in 1 rounds
-
Latest Funding Round
$253.19 K (USD), Seed
Jul 01, 2012
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Algentech
Algentech offers a comprehensive portfolio of products and services, including Bioproduction Platform, Melanin, Antimicrobials, and Nucleic Acids. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for customized plant-based biomolecule production
Pigment for industrial applications via sustainable methods
Agents to combat microbes in eco-friendly ways
DNA and RNA produced for pharmaceutical uses
Funding Insights of Algentech
Algentech has successfully raised a total of $253.19K through 1 strategic funding round. The most recent funding activity was a Seed round of $253.19 thousand completed in July 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $253,192
-
First Round
First Round
(01 Jul 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2012 | Amount | Seed - Algentech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Algentech
Algentech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Intuitis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Algentech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Algentech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Algentech Comparisons
Competitors of Algentech
Algentech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Provider of plant-based food ingredients
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Algentech
When was Algentech founded?
Algentech was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is Algentech located?
Algentech is headquartered in Evry-courcouronnes, France. It is registered at Evry-courcouronnes, Essonne, France.
Is Algentech a funded company?
Algentech is a funded company, having raised a total of $253.19K across 1 funding round to date. The company's 1st funding round was a Seed of $253.19K, raised on Jul 01, 2012.
What does Algentech do?
Algentech was founded in 2009 and is based in Evry Courcouronnes, France, within the biotechnology sector focused on agriculture. Proprietary technologies for targeting genes in plant nuclei, transforming chloroplasts, and transporting genetic information into mitochondria are provided. Efforts are directed toward developing amylose-rich wheat lines, tools for transient genetic expression in chloroplasts to avoid nuclear insertions, and cytoplasmic male sterility lines for plant breeding applications.
Who are the top competitors of Algentech?
Algentech's top competitors include Benson Hill, Sutro Biopharma and Cibus.
What products or services does Algentech offer?
Algentech offers Bioproduction Platform, Melanin, Antimicrobials, and Nucleic Acids.
Who are Algentech's investors?
Algentech has 1 investor. Key investors include Intuitis.